COVID-19 causes 'hyperactivity' in blood-clotting cells – @theU

Researchers found that inflammatory proteins produced by the virus significantly alter the function of platelets.

Mechanisms of endothelial activation, hypercoagulation and

International consortium investigates overactive immune cells as

Life, Free Full-Text

Long COVID research after the public health emergency ends : Short

Blood clot risk remains elevated nearly a year after COVID-19

Hashem Al-Ghaili - Blood clots observed in young COVID-19 patients

How does COVID-19 increase clotting risk?

Vaccines and blood clots? COVID blood clots are a greater concern

Rare Blood Clotting Disorder Risk Higher Following COVID-19 Than

New U of U study finds COVID-19 causes 'hyperactivity' in blood

Haemoperfusion should only be used for COVID-19 in the context of

COVID-19 Causes 'Hyperactivity' in Blood-Clotting Cells